Main menu
Click categories to expand
A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing
This is an alphabetical index of all content pages.
Other categories
Utilities
Also see
Importance Ratings
News
Legal
Donate/Sponsor
Curator's rationale
AI Policy
Twitter feed ð•
Feeds + s.e.o. etc.
rss / xml feed 
sitemap file
A-Z listing (archived)
Gemfibrozil - sold under brand name of Lopid, Jezil and others - is used to treat abnormal blood lipid levels. Currently around 4 million prescriptions per year in the US alone. Its mechanism of action is, to date, unknown.
The exact mechanism of action of gemfibrozil is unknown; however, several theories exist regarding the very low density lipoprotein (VLDL) effect; it can inhibit lipolysis and decrease subsequent hepatic fatty acid uptake as well as inhibit hepatic secretion of VLDL; together these actions decrease serum VLDL levels and increase HDL-cholesterol; the mechanism behind HDL elevation is currently unknown.
Source Wikipedia
Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.
DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK DECEMBER 2023